Clover Health Investments (CLOV) Change in Receivables (2020 - 2026)

Clover Health Investments' Change in Receivables history runs 7 years deep, the most recent figure standing at -$21.4 million for Q1 2026.

• Quarterly Change in Receivables fell 1174.97% year-over-year to -$21.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (up 165.74% YoY) and the FY2025 annual result came in at $43.3 million, up 443.18% from the prior year.
• Change in Receivables was -$21.4 million for Q1 2026 at Clover Health Investments, down from $36.9 million in the prior quarter.
• Across five years, Change in Receivables topped out at $36.9 million in Q4 2025 and bottomed at -$29.4 million in Q3 2024.
• A 5-year average of $1.5 million and a median of $807000.0 in 2023 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2022 — Change in Receivables jumped 2091.55% — and 2024, when it sank 3746.22%.
• Clover Health Investments' Change in Receivables stood at $11.7 million in 2022, then gained by 3.16% to $12.1 million in 2023, then rose by 17.65% to $14.2 million in 2024, then jumped by 159.58% to $36.9 million in 2025, then sank by 157.93% to -$21.4 million in 2026.
• Business Quant data shows CLOV's Change in Receivables at -$21.4 million in Q1 2026, $36.9 million in Q4 2025, and $11.0 million in Q3 2025.